Consensus EPS · Q2 2026
$2.73
Consensus revenue · Q2 2026
$976.1M
Analysts
9
Expected report
Aug 5, 2026
What to watch
- Analyst ratings: Downgrades trending
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $958M | $976.1M | $1B |
| EPS | $2.68 | $2.73 | $2.91 |
| EBITDA | $187.9M | $190.4M | $192.3M |
| EBIT | $107.5M | $109M | $110.1M |
| Net income | $132.6M | $134.1M | $137.5M |
- Revenue$976.1M
- EPS$2.73
- EBITDA$190.4M
- EBIT$109M
- Net income$134.1M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $995.8M | $977.5M | +1.9% | $2.06 | $1.94 | +6.0% |
- Q1 2026+1.9%+6.0%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Charles River (CRL) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 4 analysts.
- Low
- $213.00
- Consensus
- $230.78
- Median
- $220.00
- High
- $260.00
- Current
- $218.70
- Upside
- +5.5%
Upside calculated vs most recent trading price of $218.70.
Analyst ratings
Consensus: Buy — based on 37 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2026 | CLSA | downgrade | Outperform | Hold |
| Jul 13, 2026 | Mizuho | maintain | Neutral | Neutral |
| Jul 9, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Jun 17, 2026 | Morgan Stanley | upgrade | Equal Weight | Overweight |
| May 29, 2026 | CLSA | upgrade | Hold | Outperform |
| May 8, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| May 8, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 14, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 13, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Feb 25, 2026 | UBS | maintain | Neutral | Neutral |
- Jul 20, 2026CLSAHold
- Jul 13, 2026MizuhoNeutral
- Jul 9, 2026Morgan StanleyOverweight
- Jun 17, 2026Morgan StanleyOverweight
- May 29, 2026CLSAOutperform
- May 8, 2026Evercore ISI GroupOutperform
- May 8, 2026BarclaysOverweight
- Apr 14, 2026BarclaysOverweight
- Apr 13, 2026JP MorganNeutral
- Feb 25, 2026UBSNeutral
Frequently asked questions
Charles River (CRL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.